Literature DB >> 19786743

Pediatric inflammatory bowel disease: is it different?

Arie Levine1.   

Abstract

The clinical manifestations of Crohn's disease (CD) and ulcerative colitis (UC) are highly variable, with significant diversity in phenotypes of the diseases. This diversity may manifest as a difference in age of onset. Pediatric-onset disease may present differently and have a different natural history, with ramifications for disease management. Clear evidence exists at present that pediatric-onset UC may be different than adult-onset UC. The primary difference in disease phenotype is extent of disease. Approximately 60-70% of patients with pediatric-onset UC present with pancolitis, as opposed to approximately 20-30% in adults. Patients are more likely to have severe disease and become steroid-dependent. CD may be affected by an age gradient. There is an inverse linear relationship between age and colonic CD, the younger the patient, the more likely is the patient to have colonic CD. This inverse relationship is true through age 10. In addition, pediatric patients are more likely to have upper gastrointestinal involvement than their adult peers. Comparing adult and pediatric phenotypes is fraught with methodological obstacles. Disease behavior, with the exception of growth failure, seems to parallel disease behavior in adults. Patients with growth retardation are a high risk group for complications and should be managed as such. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19786743     DOI: 10.1159/000228552

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  15 in total

1.  The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population.

Authors:  Jerzy Mrowicki; Karolina Przybylowska-Sygut; Lukasz Dziki; Andrzej Sygut; Jan Chojnacki; Adam Dziki; Ireneusz Majsterek
Journal:  Mol Biol Rep       Date:  2014-04-01       Impact factor: 2.316

2.  Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn's disease: preliminary report.

Authors:  Antonella Diamanti; Daniela Knafelz; Fabio Panetta; Fiammetta Bracci; Manuela Gambarara; Bronislava Papadatou; Antonella Daniele; Bianca M Goffredo; Simona Pezzi; Giuliano Torre
Journal:  Int J Colorectal Dis       Date:  2011-06-14       Impact factor: 2.571

3.  Serum protein profiling of adults and children with Crohn disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; Aggeliki Papadopoulou; Athanassios K Anagnostopoulos; George Karamanolis; George E Theodoropoulos; Amosy M'Koma; George T Tsangaris
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

4.  Eosinophil progenitor levels correlate with tissue pathology in pediatric eosinophilic esophagitis.

Authors:  Justin T Schwartz; David W Morris; Margaret H Collins; Marc E Rothenberg; Patricia C Fulkerson
Journal:  J Allergy Clin Immunol       Date:  2018-11-09       Impact factor: 10.793

Review 5.  Development of biomarkers to optimize pediatric patient management: what makes children different?

Authors:  Jennifer Goldman; Mara L Becker; Bridgette Jones; Mark Clements; J Steven Leeder
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

6.  [Chronically ill children become grown-up. What does the internist learn from the pediatrician?].

Authors:  C M Gelbmann; M Melter
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

7.  The histopathological approach to inflammatory bowel disease: a practice guide.

Authors:  Cord Langner; Fernando Magro; Ann Driessen; Arzu Ensari; Gerassimos J Mantzaris; Vincenzo Villanacci; Gabriel Becheanu; Paula Borralho Nunes; Gieri Cathomas; Walter Fries; Anne Jouret-Mourin; Claudia Mescoli; Giovanni de Petris; Carlos A Rubio; Neil A Shepherd; Michael Vieth; Rami Eliakim; Karel Geboes
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

8.  Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring.

Authors:  M H Collins; L J Martin; E S Alexander; J Todd Boyd; R Sheridan; H He; S Pentiuk; P E Putnam; J P Abonia; V A Mukkada; J P Franciosi; M E Rothenberg
Journal:  Dis Esophagus       Date:  2017-02-01       Impact factor: 3.429

Review 9.  Etiology of inflammatory bowel disease: a unified hypothesis.

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

10.  Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.

Authors:  Barbara Dorottya Lovasz; Laszlo Lakatos; Agnes Horvath; Istvan Szita; Tunde Pandur; Michael Mandel; Zsuzsanna Vegh; Petra Anna Golovics; Gabor Mester; Mihaly Balogh; Csaba Molnar; Erzsebet Komaromi; Lajos Sandor Kiss; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.